2010
DOI: 10.3109/10717544.2010.483252
|View full text |Cite
|
Sign up to set email alerts
|

Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
60
0
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(64 citation statements)
references
References 24 publications
3
60
0
1
Order By: Relevance
“…An aqueous phase was prepared by dissolving PVA (0.25%) in water and was heated to the same temperature as the organic phase. The organic phase was added dropwise by means of a hypodermic needle to the pre-heated aqueous phase with continuous stirring [26]. The mixture was allowed to cool and was sonicated (Hielscher UP 200ST, South Africa) for varying periods of time until nano-vesicles of the desired size were obtained.…”
Section: Preparation Of Artemisone-loaded Slnsmentioning
confidence: 99%
“…An aqueous phase was prepared by dissolving PVA (0.25%) in water and was heated to the same temperature as the organic phase. The organic phase was added dropwise by means of a hypodermic needle to the pre-heated aqueous phase with continuous stirring [26]. The mixture was allowed to cool and was sonicated (Hielscher UP 200ST, South Africa) for varying periods of time until nano-vesicles of the desired size were obtained.…”
Section: Preparation Of Artemisone-loaded Slnsmentioning
confidence: 99%
“…The density of inoculums was adjusted by measuring the optical density of the microbial suspension. About 75 µl Candida albicans culture (cfu/ml 10 8 ) was injected subcutaneously and 25µl candida culture was applied topically on the exposed skin[24][25][26]. Symptoms of infection were observed in 24-48 hours.…”
mentioning
confidence: 99%
“…[14][15][16] These systems have been shown to enhance the antifungal activity of miconazole. 4 To date, 17,18 Solid lipid nanoparticles (SLNs) were developed at the beginning of the 1990s as an alternative particulate delivery system to liposomes, emulsions, microparticles, and polymeric nanoparticulate systems. SLNs combine the advantages of those systems, such as controlled release, biodegradability, biocompatibility, and the protection of the incorporated drug against chemical degradation.…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Miconazole is a weak base and shows poor aqueous solubility (,1 µg/mL); as a result, a reduction in its therapeutic efficacy has been reported. 3,4 Miconazole has a dual mechanism of action: the inhibition of ergosterol biosynthesis and the inhibition of peroxidases, which causes the accumulation of peroxide within the cell, leading to cell death. 5,6 This antifungal drug is available in different dosage forms, including topical, oral, and parenteral, depending on the type and severity of infection.…”
Section: Introductionmentioning
confidence: 99%